142 related articles for article (PubMed ID: 31217965)
21. Discovery and characterization of a monogenetic insult, caveolin-3-V37L, that precipitated oligo-proteomic perturbations governing repolarization reserve.
Ye D; Zhou W; Tester DJ; Ackerman MJ
Int J Cardiol; 2020 Nov; 319():71-77. PubMed ID: 32387251
[TBL] [Abstract][Full Text] [Related]
22. Resolving the Reversed Rate Effect of Calcium Channel Blockers on Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes and the Impact on In Vitro Cardiac Safety Evaluation.
Zeng H; Wang J; Clouse H; Lagrutta A; Sannajust F
Toxicol Sci; 2019 Feb; 167(2):573-580. PubMed ID: 30365015
[TBL] [Abstract][Full Text] [Related]
23. Proarrhythmia Risk Assessment in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Using the Maestro MEA Platform.
Qu Y; Vargas HM
Toxicol Sci; 2015 Sep; 147(1):286-95. PubMed ID: 26117837
[TBL] [Abstract][Full Text] [Related]
24. HiPSC-CMs from different sex and ethnic origin donors exhibit qualitatively different responses to several classes of pharmacological challenges.
Zeng H; Wang J; Clouse H; Lagrutta A; Sannajust F
J Pharmacol Toxicol Methods; 2019; 99():106598. PubMed ID: 31201864
[TBL] [Abstract][Full Text] [Related]
25. Complex aberrant splicing in the induced pluripotent stem cell-derived cardiomyocytes from a patient with long QT syndrome carrying KCNQ1-A344Aspl mutation.
Wuriyanghai Y; Makiyama T; Sasaki K; Kamakura T; Yamamoto Y; Hayano M; Harita T; Nishiuchi S; Chen J; Kohjitani H; Hirose S; Yokoi F; Gao J; Chonabayashi K; Watanabe K; Ohno S; Yoshida Y; Kimura T; Horie M
Heart Rhythm; 2018 Oct; 15(10):1566-1574. PubMed ID: 29857160
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms of acquired long QT syndrome in patients with propionic academia.
Bodi I; Grünert SC; Becker N; Stoelzle-Feix S; Spiekerkoetter U; Zehender M; Bugger H; Bode C; Odening KE
Heart Rhythm; 2016 Jun; 13(6):1335-45. PubMed ID: 26854997
[TBL] [Abstract][Full Text] [Related]
27. Phenotypic variability in LQT3 human induced pluripotent stem cell-derived cardiomyocytes and their response to antiarrhythmic pharmacologic therapy: An in silico approach.
Paci M; Passini E; Severi S; Hyttinen J; Rodriguez B
Heart Rhythm; 2017 Nov; 14(11):1704-1712. PubMed ID: 28756098
[TBL] [Abstract][Full Text] [Related]
28. Recessive cardiac phenotypes in induced pluripotent stem cell models of Jervell and Lange-Nielsen syndrome: disease mechanisms and pharmacological rescue.
Zhang M; D'Aniello C; Verkerk AO; Wrobel E; Frank S; Ward-van Oostwaard D; Piccini I; Freund C; Rao J; Seebohm G; Atsma DE; Schulze-Bahr E; Mummery CL; Greber B; Bellin M
Proc Natl Acad Sci U S A; 2014 Dec; 111(50):E5383-92. PubMed ID: 25453094
[TBL] [Abstract][Full Text] [Related]
29. Human induced pluripotent stem cell-derived versus adult cardiomyocytes: an in silico electrophysiological study on effects of ionic current block.
Paci M; Hyttinen J; Rodriguez B; Severi S
Br J Pharmacol; 2015 Nov; 172(21):5147-60. PubMed ID: 26276951
[TBL] [Abstract][Full Text] [Related]
30. Restricting excessive cardiac action potential and QT prolongation: a vital role for IKs in human ventricular muscle.
Jost N; Virág L; Bitay M; Takács J; Lengyel C; Biliczki P; Nagy Z; Bogáts G; Lathrop DA; Papp JG; Varró A
Circulation; 2005 Sep; 112(10):1392-9. PubMed ID: 16129791
[TBL] [Abstract][Full Text] [Related]
31. Ionic mechanisms limiting cardiac repolarization reserve in humans compared to dogs.
Jost N; Virág L; Comtois P; Ordög B; Szuts V; Seprényi G; Bitay M; Kohajda Z; Koncz I; Nagy N; Szél T; Magyar J; Kovács M; Puskás LG; Lengyel C; Wettwer E; Ravens U; Nánási PP; Papp JG; Varró A; Nattel S
J Physiol; 2013 Sep; 591(17):4189-206. PubMed ID: 23878377
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of IKs channels by HMR 1556.
Gögelein H; Brüggemann A; Gerlach U; Brendel J; Busch AE
Naunyn Schmiedebergs Arch Pharmacol; 2000 Dec; 362(6):480-8. PubMed ID: 11138839
[TBL] [Abstract][Full Text] [Related]
33. Electrophysiological characteristics and pharmacological sensitivity of two lines of human induced pluripotent stem cell derived cardiomyocytes coming from two different suppliers.
Goineau S; Castagné V
J Pharmacol Toxicol Methods; 2018; 90():58-66. PubMed ID: 29274391
[TBL] [Abstract][Full Text] [Related]
34. L-Type Calcium Channel Inhibition Contributes to the Proarrhythmic Effects of Aconitine in Human Cardiomyocytes.
Wu J; Wang X; Chung YY; Koh CH; Liu Z; Guo H; Yuan Q; Wang C; Su S; Wei H
PLoS One; 2017; 12(1):e0168435. PubMed ID: 28056022
[TBL] [Abstract][Full Text] [Related]
35. CSAHi study: Detection of drug-induced ion channel/receptor responses, QT prolongation, and arrhythmia using multi-electrode arrays in combination with human induced pluripotent stem cell-derived cardiomyocytes.
Kitaguchi T; Moriyama Y; Taniguchi T; Maeda S; Ando H; Uda T; Otabe K; Oguchi M; Shimizu S; Saito H; Toratani A; Asayama M; Yamamoto W; Matsumoto E; Saji D; Ohnaka H; Miyamoto N
J Pharmacol Toxicol Methods; 2017; 85():73-81. PubMed ID: 28163191
[TBL] [Abstract][Full Text] [Related]
36. Characterization of the CACNA1C-R518C Missense Mutation in the Pathobiology of Long-QT Syndrome Using Human Induced Pluripotent Stem Cell Cardiomyocytes Shows Action Potential Prolongation and L-Type Calcium Channel Perturbation.
Estes SI; Ye D; Zhou W; Dotzler SM; Tester DJ; Bos JM; Kim CSJ; Ackerman MJ
Circ Genom Precis Med; 2019 Aug; 12(8):e002534. PubMed ID: 31430211
[TBL] [Abstract][Full Text] [Related]
37. Human leukocyte antigen F-associated transcript 10 regulates the
Chen C; Zhu X; Xie J; Li X; Wan R; Hong K
Philos Trans R Soc Lond B Biol Sci; 2023 Jun; 378(1879):20220167. PubMed ID: 37122222
[TBL] [Abstract][Full Text] [Related]
38. The electrophysiological effects of cardiac glycosides in human iPSC-derived cardiomyocytes and in guinea pig isolated hearts.
Guo L; Qian JY; Abrams R; Tang HM; Weiser T; Sanders MJ; Kolaja KL
Cell Physiol Biochem; 2011; 27(5):453-62. PubMed ID: 21691062
[TBL] [Abstract][Full Text] [Related]
39. Ionic Mechanisms of Disopyramide Prolonging Action Potential Duration in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes From a Patient With Short QT Syndrome Type 1.
Lan H; Xu Q; El-Battrawy I; Zhong R; Li X; Lang S; Cyganek L; Borggrefe M; Zhou X; Akin I
Front Pharmacol; 2020; 11():554422. PubMed ID: 33154722
[TBL] [Abstract][Full Text] [Related]
40. Human stem cell-derived cardiomyocytes detect drug-mediated changes in action potentials and ion currents.
Gibson JK; Yue Y; Bronson J; Palmer C; Numann R
J Pharmacol Toxicol Methods; 2014; 70(3):255-67. PubMed ID: 25219538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
